190 related articles for article (PubMed ID: 20878505)
21. Modular anti-EGFR and anti-Her2 targeting of SK-BR-3 and BT474 breast cancer cell lines in the presence of ErbB receptor-specific growth factors.
Diermeier-Daucher S; Breindl S; Buchholz S; Ortmann O; Brockhoff G
Cytometry A; 2011 Sep; 79(9):684-93. PubMed ID: 21786419
[TBL] [Abstract][Full Text] [Related]
22. Intra- and extracellular signaling by endothelial neuregulin-1.
Iivanainen E; Paatero I; Heikkinen SM; Junttila TT; Cao R; Klint P; Jaakkola PM; Cao Y; Elenius K
Exp Cell Res; 2007 Aug; 313(13):2896-909. PubMed ID: 17499242
[TBL] [Abstract][Full Text] [Related]
23. Dysregulation of the neuregulin-1-ErbB network modulates endogenous oligodendrocyte differentiation and preservation after spinal cord injury.
Gauthier MK; Kosciuczyk K; Tapley L; Karimi-Abdolrezaee S
Eur J Neurosci; 2013 Sep; 38(5):2693-715. PubMed ID: 23758598
[TBL] [Abstract][Full Text] [Related]
24. Endothelium-derived neuregulin protects the heart against ischemic injury.
Hedhli N; Huang Q; Kalinowski A; Palmeri M; Hu X; Russell RR; Russell KS
Circulation; 2011 May; 123(20):2254-62. PubMed ID: 21555713
[TBL] [Abstract][Full Text] [Related]
25. EGFR and ErbB2 are functionally coupled to CD44 and regulate shedding, internalization and motogenic effect of CD44.
Pályi-Krekk Z; Barok M; Kovács T; Saya H; Nagano O; Szöllosi J; Nagy P
Cancer Lett; 2008 May; 263(2):231-42. PubMed ID: 18276068
[TBL] [Abstract][Full Text] [Related]
26. The neuregulin-I/ErbB signaling system in development and disease.
Britsch S
Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
[TBL] [Abstract][Full Text] [Related]
27. Neuregulin-1/ErbB signaling and chronic heart failure.
Xu Y; Li X; Liu X; Zhou M
Adv Pharmacol; 2010; 59():31-51. PubMed ID: 20933198
[TBL] [Abstract][Full Text] [Related]
28. Neuregulin-1alpha and beta isoform expression in cardiac microvascular endothelial cells and function in cardiac myocytes in vitro.
Cote GM; Miller TA; Lebrasseur NK; Kuramochi Y; Sawyer DB
Exp Cell Res; 2005 Nov; 311(1):135-46. PubMed ID: 16185687
[TBL] [Abstract][Full Text] [Related]
29. Specific blockade of VEGF and HER2 pathways results in greater growth inhibition of breast cancer xenografts that overexpress HER2.
Le XF; Mao W; Lu C; Thornton A; Heymach JV; Sood AK; Bast RC
Cell Cycle; 2008 Dec; 7(23):3747-58. PubMed ID: 19029832
[TBL] [Abstract][Full Text] [Related]
30. Can trastuzumab be effective against tumors with low HER2/Neu (ErbB2) receptors?
Arteaga CL
J Clin Oncol; 2006 Aug; 24(23):3722-5. PubMed ID: 16847283
[No Abstract] [Full Text] [Related]
31. Constitutive activation of the neuregulin-1/erbB signaling pathway promotes the proliferation of a human peripheral neuroepithelioma cell line.
Fallon KB; Havlioglu N; Hamilton LH; Cheng TP; Carroll SL
J Neurooncol; 2004 Feb; 66(3):273-84. PubMed ID: 15015657
[TBL] [Abstract][Full Text] [Related]
32. RhNRG-1β Protects the Myocardium against Irradiation-Induced Damage via the ErbB2-ERK-SIRT1 Signaling Pathway.
Gu A; Jie Y; Sun L; Zhao S; E M; You Q
PLoS One; 2015; 10(9):e0137337. PubMed ID: 26332771
[TBL] [Abstract][Full Text] [Related]
33. Neuregulin signaling and heart failure.
Jiang Z; Zhou M
Curr Heart Fail Rep; 2010 Mar; 7(1):42-7. PubMed ID: 20425496
[TBL] [Abstract][Full Text] [Related]
34. Neuregulin signaling regulates neural precursor growth and the generation of oligodendrocytes in vitro.
Calaora V; Rogister B; Bismuth K; Murray K; Brandt H; Leprince P; Marchionni M; Dubois-Dalcq M
J Neurosci; 2001 Jul; 21(13):4740-51. PubMed ID: 11425901
[TBL] [Abstract][Full Text] [Related]
35. Neuregulin‑1: An underlying protective force of cardiac dysfunction in sepsis (Review).
Kang W; Cheng Y; Wang X; Zhou F; Zhou C; Wang L; Zhong L
Mol Med Rep; 2020 Jun; 21(6):2311-2320. PubMed ID: 32236630
[TBL] [Abstract][Full Text] [Related]
36. Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors.
Kirouac DC; Du JY; Lahdenranta J; Overland R; Yarar D; Paragas V; Pace E; McDonagh CF; Nielsen UB; Onsum MD
Sci Signal; 2013 Aug; 6(288):ra68. PubMed ID: 23943608
[TBL] [Abstract][Full Text] [Related]
37. The role of endothelial autocrine NRG1/ERBB4 signaling in cardiac remodeling.
Dugaucquier L; Feyen E; Mateiu L; Bruyns TAM; De Keulenaer GW; Segers VFM
Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H443-H455. PubMed ID: 32618511
[TBL] [Abstract][Full Text] [Related]
38. Esophageal Adenocarcinoma Cells and Xenograft Tumors Exposed to Erb-b2 Receptor Tyrosine Kinase 2 and 3 Inhibitors Activate Transforming Growth Factor Beta Signaling, Which Induces Epithelial to Mesenchymal Transition.
Ebbing EA; Steins A; Fessler E; Stathi P; Lesterhuis WJ; Krishnadath KK; Vermeulen L; Medema JP; Bijlsma MF; van Laarhoven HWM
Gastroenterology; 2017 Jul; 153(1):63-76.e14. PubMed ID: 28286209
[TBL] [Abstract][Full Text] [Related]
39. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity.
Anjos M; Fontes-Oliveira M; Costa VM; Santos M; Ferreira R
Life Sci; 2021 Sep; 280():119760. PubMed ID: 34166713
[TBL] [Abstract][Full Text] [Related]
40. Activation of ErbB2 by overexpression or by transmembrane neuregulin results in differential signaling and sensitivity to herceptin.
Yuste L; Montero JC; Esparís-Ogando A; Pandiella A
Cancer Res; 2005 Aug; 65(15):6801-10. PubMed ID: 16061662
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
